You are here: Introduction > Contra-indications, warnings, etc
 
        PreviousNext
 
Canigen DHP:  Contra-indications, warnings, etc
 
 
Canigen DHP
Contra-indications, warnings, etc
After subcutaneous administration with Canigen Solvent or Canigen Lepto 2 a diffuse swelling, up to 5 mm in diameter, may be observed at the site of injection in approximately 10% of animals. Occasionally this swelling may be hard and painful and last for up to 3 days post injection.
After subcutaneous administration with Canigen Rabies, transient local reactions such as diffuse to firm swellings from 1 to 4 cm in diameter may be observed for up to 3 weeks after vaccination. The swellings may be painful for up to 3 days post dosing.
In very rare cases a transient rise in body temperature and/or a transient acute hypersensitivity reaction (anaphylaxis) - with signs that may include lethargy, facial oedema, pruritus, dyspnoea, vomiting, diarrhoea or collapse - may occur shortly after vaccination.
Only healthy dogs should be vaccinated. Dogs should not be exposed to unnecessary risk of infection within the first 2 weeks after completion of the vaccination regimen.
While the canine parvovirus vaccine strain may be shed at very low levels for up to 8 days after inoculation, there is no evidence that this results in clinical symptoms if non-vaccinated animals are infected.
No information is available on the safety and efficacy of this vaccine when used with any other vaccine except Canigen Lepto 2 or Canigen Rabies. It is therefore recommended that no other vaccines than these should be administered within 14 days before or after vaccination with Canigen DHP.
Do not mix with any other vaccine/immunological product except with Canigen Solvent, Canigen Lepto 2 or Canigen Rabies.
The efficacy of the CDV, CAV2 and CPV components of the vaccine may be reduced due to maternal antibody interference. However, the vaccine has been proved to be of benefit against virulent challenge in the presence of maternal antibody levels to CDV, CAV2 and CPV that are likely to be encountered under field conditions.
Operator warnings
In the case of accidental self-injection, wash the area immediately with water. If symptoms develop, seek medical attention showing a copy of the product literature.
Withdrawal period
Not applicable.
For animal treatment only. Keep out of reach and sight of children.
           
 
        PreviousNext
  Date updated: 29 September 2006